Loading...
V S International Private Limited — Valacyclovir Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #4 for Valacyclovir · $1.3M export value · DGFT Verified
V S International Private Limited is the #4 Indian exporter of Valacyclovir with $1.3M in export value and 37 verified shipments. V S International Private Limited holds a 1.4% market share in Valacyclovir exports across 1 countries. The company exports 6 pharmaceutical products worth $7.3M across 5 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $14.3M | 285 | 63.7% |
| CANADA | $2.4M | 48 | 10.7% |
| SWEDEN | $1.9M | 38 | 8.3% |
| TAIWAN | $1.4M | 27 | 6.0% |
| SAUDI ARABIA | $500.0K | 10 | 2.2% |
| SINGAPORE | $359.4K | 635 | 1.6% |
| RUSSIA | $345.0K | 9 | 1.5% |
| MALAYSIA | $265.7K | 9 | 1.2% |
| PHILIPPINES | $258.9K | 25 | 1.2% |
| MAURITIUS | $196.3K | 210 | 0.9% |
India exports Valacyclovir to 70 countries. The top destination is UNITED STATES (63.7%), followed by CANADA and SWEDEN.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| XXMBEXXPHAXXACEXXICAXX IXX | UNITED STATES | $2.5M | 49 |
| SIVEM PHARMACEUTICALS | UNITED STATES | $1.6M | 31 |
| JAMP PHARMA CORPORATION | CANADA | $1.3M | 37 |
| MYLAN PHARMACEUTICALS INC, | UNITED STATES | $1.1M | 23 |
| CAMBER PHARMACEUTICALS INC | UNITED STATES |
India exported $21.1M worth of Valacyclovir through 2,537 shipments from 113 suppliers to 70 countries, serving 197 buyers globally. V S International Private Limited contributes $1.3M to this total, accounting for 1.4% of India's Valacyclovir exports.
V S International Private Limited's average Valacyclovir shipment value is $35.6K per consignment, based on 37 shipments totaling $1.3M.
V S International Private Limited ranks #4 among 113 Indian Valacyclovir exporters with a 1.4% market share. The top 3 exporters are HETERO LABS LIMITED ($12.6M), MYLAN LABORATORIES LIMITED ($3.1M), AUROBINDO PHARMA LTD ($2.0M). V S International Private Limited processed 37 shipments to 1 destination countries.
What V S International Private Limited must comply with to export Valacyclovir to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $3.1M | 62 | 3 | $50.0K |
| 3 | AUROBINDO PHARMA LTD | $2.0M | 41 | 2 | $50.0K |
| 4 | V S INTERNATIONAL PRIVATE LIMITED ★ | $1.3M | 37 | 1 | $35.6K |
| 6 | CIPLA LIMITED | $455.8K | 15 |
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 571 | 22.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 495 | 19.5% |
| SAHAR AIR | 366 | 14.4% |
| DELHI AIR | 311 | 12.3% |
| Delhi Air | 110 | 4.3% |
| Bombay Air | 107 | 4.2% |
| BANGALORE ICD (INWFD6) | 60 | 2.4% |
| NHAVA SHEVA SEA (INNSA1) | 54 | 2.1% |
V S International Private Limited also exports these antivirals products. Each links to the detailed product page.
V S International Private Limited exports 6 products worth $7.3M. Beyond Valacyclovir, top products include Ciprofloxacin, Acyclovir, Melatonin, Tinidazole, Epirubicin. View the complete V S International Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Valacyclovir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for V S International Private Limited's Valacyclovir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
V S International Private Limited
Full Company Profile →
6 products · $7.3M total trade · 5 categories
| $1.1M |
| 23 |
| MYLAN PHARMACEUTICALS INC | UNITED STATES | $1.1M | 21 |
| M/S. MYLAN PHARMACEUTICALS INC, | UNITED STATES | $550.0K | 11 |
| CAMBER PHARMACEUTICALS INC. | UNITED STATES | $350.0K | 7 |
| NORTHSTAR HEALTHCARE | UNITED STATES | $300.0K | 6 |
| MYLAN PHARMACEUTICALS ULC | CANADA | $200.0K | 4 |
India's Valacyclovir is purchased by 197 buyers worldwide. The top buyer is XXMBEXXPHAXXACEXXICAXX IXX (UNITED STATES), followed by SIVEM PHARMACEUTICALS and JAMP PHARMA CORPORATION.
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| 2 |
| $30.4K |
| 8 | JUBILANT GENERICS LTD | $287.8K | 6 | 1 | $48.0K |
V S International Private Limited ranks #4 among 113 Indian Valacyclovir exporters. Average shipment value of $35.6K compared to the market average of $187.0K. The closest competitors by value are MYLAN LABORATORIES LIMITED and AUROBINDO PHARMA LTD.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 70+ countries, 197+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for V S International Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Valacyclovir. For current shipment-level data, contact TransData Nexus.